Sonja Nesbit News Today

This digest covers key virtual and digital health regulatory and public policy developments during April and early May 2024 from the United States, United Kingdom, and European Union.

There's only six months until Election Day, but we can't write off 2024 as just another "election year." Our policy analysts with decades of Hill experience discuss how the seeds...

In an election year, spring in Washington, D.C. brings cherry blossoms, pollen, and serious pressure to move legislation before the summer campaign season.

Secretary Becerra reiterated HHS commitment to continued partnership with insurance providers to ensure that consumers can receive updated COVID-19 vaccines

Everett Eissenstat plans to be busy right away. “You know, trade kind of ebbs and flows,” he said in an interview.

Independent experts for the CDC start meeting today to consider the latest data on vaccines for nearly a dozen illnesses and potentially recommend some for the public.

The blockbuster weight loss drugs' access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.

Restrictions to the pills aren’t new, with 18 states already limiting them as part of near-total abortion bans.

Republicans also likely to focus on administration's handling of COVID, other health issues

FDA advisers voted in favor of pulling preterm-birth drug Makena from the market last week.